JPRN-C000000145已完成未知
Dose-intensive weekly combination chemotherapy (cisplatin, vincristine, doxorubicin and etoposide) followed by cisplatin-etoposide therapy with concurrent thoracic irradiation: evaluation of a new treatment for limited-disease small-cell lung cancer. - Dose-intensive weekly combination chemotherapy (cisplatin, vincristine, doxorubicin and etoposide) followed by cisplatin-etoposide therapy with concurrent thoracic irradiation: evaluation of a new treatment for limited-disease small-cell lung cancer.
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The criteria were age ≥ to 18 years and ≤ 70years, no concurrent active malignancies.
研究者
相似试验
已完成
不适用
Weekly intensive versus standard chemotherapy in untreated small cell lung cancer (SCLC) patients with good prognosisung (small cell) cancerLung (small cell) cancerCancerISRCTN26181691Cancer Research UK (CRUK) (UK)
进行中（未招募）
不适用
Treatment With Chemotherapy and Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)Diffuse Large B Cell Lymphoma and HIV InfectionEUCTR2006-003750-23-ESFundación PETHEMA
已完成
1 期
Dose finding study of the combination chemotherapy consisting of irinotecan hydrochloride and pegylated liposomal doxorubicin combination therapy in patients with recurrent ovarian cancer (Phase I trial)Epithelial ovarian cancer, primary fallopian tube cancer, or peritoneal cancer recurred during the present chemotherapy or within 6 months after the prior chemotherapy.JPRN-UMIN000004602School of Medicine, Keio University Obstetrics and Gynecology18
已完成
2 期
A Phase II study of combination chemotherapy including Bortezomib in pediatric patients with relapsed acute lymphoblastic leukemia (Investigator-initiated clinical trial)A high-risk group of pediatric patients with first relapse of ALLor refractory ALL (patients who develop 2nd or subsequent relapse, relapse after hematopoietic cell transplantation or fail to achieve remission induction with one or more therapies).JPRN-UMIN000023815Department of Pediatric Oncology, National Cancer Center Hospital22
已完成
4 期
A multicentre study using the chemotherapy combination of bi-monthly Xeloda and Eloxatin, with the addition of Avastin, in patients with advanced colorectal cancerCancerColorectal cancerISRCTN41540878Cancer Trials New Zealand (CTNZ)60